• 2022-07-06
    Last Updated
  • 200
    Pages

Asthma Medication Market - Forecast(2022 - 2030)

DESCRIPTION
TABLE OF CONTENT

marketreports.info delivers well-researched industry-wide information on the Asthma Medication market. It provides information on the market’s essential aspects such as top participants, factors driving Asthma Medication market growth, precise estimation of the Asthma Medication market size, upcoming trends, changes in consumer behavioral pattern, market’s competitive landscape, key market vendors, and other market features to gain an in-depth analysis of the Asthma Medication market. Additionally, the report is a compilation of both qualitative and quantitative assessment by industry experts, as well as industry participants across the value chain. The Asthma Medication report also focuses on the latest developments that can enhance the performance of various market segments.

This Asthma Medication report strategically examines the micro-markets and sheds light on the impact of technology upgrades on the performance of the Asthma Medication market. The Asthma Medication report presents a broad assessment of the market and contains solicitous insights, historical data, and statistically supported and industry-validated market data. The Asthma Medication report offers market projections with the help of appropriate assumptions and methodologies. The Asthma Medication research report provides information as per the market segments such as geographies, products, technologies, applications, and industries.

Key vendors engaged in the Asthma Medication market and covered in this report: GlaxoSmithKline (GSK) (United Kingdom), Novartis AG (Switzerland), Merck & Co. (United States), Abbott Laboratories (United States), Boehringer Ingelheim (Germany), AstraZeneca (United Kingdom), Roche Holding AG (Switzerland), Teva Pharmaceutical Industries (Israel), Vectura Group (United Kingdom), Pfizer (United States), MAP Pharmaceuticals, Inc. (United States), Genentech Inc. (United States), Sepracor, Inc. (United States), Schering-Plough Corp (United States), Sanofi-Aventis (France), Theravance Inc. (United States)

By Type
Quick-Relief Medications
Long-Term Control Medications
Asthma Medications During Pregnancy
By Application
Children
Adolescent
Adult
By Therapy
Reliever treatment
Maintenance treatment

By Route Of Admission
Oral
Inhaled
Intravenous
Subcutaneous

By Drug Class
Bronchodilators (beta agonists anti-cholinergics xanthines)
Leukotriene antagonists
Mast cell stabilizers
Corticosteroids
Monoclonal antibody

The Asthma Medication study conducts SWOT analysis to evaluate strengths and weaknesses of the key players in the Asthma Medication market. Further, the report conducts an intricate examination of drivers and restraints operating in the Asthma Medication market. The Asthma Medication report also evaluates the trends observed in the parent Asthma Medication market, along with the macro-economic indicators, prevailing factors, and market appeal according to different segments. The Asthma Medication report also predicts the influence of different industry aspects on the Asthma Medication market segments and regions.

Researchers also carry out a comprehensive analysis of the recent regulatory changes and their impact on the competitive landscape of the Asthma Medication industry. The Asthma Medication research assesses the recent progress in the competitive landscape including collaborations, joint ventures, product launches, acquisitions, and mergers, as well as investments in the sector for research and development.

Asthma Medication Key points from Table of Content:

Scope of the study:

The research on the Asthma Medication market focuses on mining out valuable data on investment pockets, growth opportunities, and major market vendors to help clients understand their competitor’s methodologies. The Asthma Medication research also segments the Asthma Medication market on the basis of end user, product type, application, and demography for the forecast period 2022–2030. Comprehensive analysis of critical aspects such as impacting factors and competitive landscape are showcased with the help of vital resources, such as charts, tables, and infographics.

This Asthma Medication report strategically examines the micro-markets and sheds light on the impact of technology upgrades on the performance of the Asthma Medication market.

Asthma Medication Market Segmented by Region/Country: North America, Europe, Asia Pacific, Middle East & Africa, and Central & South America

Major highlights of the Asthma Medication report:

  • All-inclusive evaluation of the Asthma Medication market
  • Evolution of significant Asthma Medication market aspects
  • Industry-wide investigation of Asthma Medication market segments
  • Assessment of Asthma Medication market value and volume in past, present, and forecast years
  • Evaluation of Asthma Medication market share
  • Study of niche Asthma Medication industrial sectors
  • Tactical approaches of Asthma Medication market leaders
  • Lucrative strategies to help companies strengthen their position in the Asthma Medication market

Thanks for reading this article; you can also customize this report to get select chapters or region-wise coverage with regions such as Asia, North America, and Europe.

Chapter 1 Global Asthma Medication Market Overview

1.1 Introduction
1.2 Taxonomy
1.2.1 By Product Type & End User
1.2.2 By Region
1.3 Drivers for Asthma Medication Market
1.4 Restraints for Asthma Medication Market
1.5 Opportunities for Asthma Medication Market
1.6 Trends for Asthma Medication Market
1.7 COVID-19 Impact Assessment on Asthma Medication Industry
1.8 Macro-economic Factors
1.9 Regulatory Framework
1.10 Pricing Analysis by Region, 2020
1.11 Opportunity Map Analysis
1.12 Opportunity Orbits
1.13 Market Investment Feasibility Index
1.14 PEST Analysis
1.15 PORTERS Five Force Analysis
1.16 Go to Market Strategy
1.17 Value Chain Analysis
1.18 Cost Structure Analysis
1.19 Regional Market Share and BPS Analysis

Chapter 2 Global Asthma Medication Market Overview

2.1 Global Asthma Medication Market by Product Type
2.1.1 Global Asthma Medication Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
2.1.2 Global Asthma Medication Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
2.1.3 Global Asthma Medication Market Attractiveness Analysis by Product Type, (2013-2020)
2.2 Global Asthma Medication Market by End User
2.2.1 Global Asthma Medication Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
2.2.2 Global Asthma Medication Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
2.2.3 Global Asthma Medication Market Attractiveness Analysis by End User, (2013-2020)
2.3 Global Asthma Medication Market by Region
2.3.1 Global Asthma Medication Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
2.3.2 Global Asthma Medication Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
2.3.3 Global Asthma Medication Market Attractiveness Analysis by Region, (2013-2020)
2.4 Global Asthma Medication Market Outlook (2013-2029)
2.4.1 Global Asthma Medication Market Value (US$ Mn) and Volume (Units) (2013-2020)
2.4.2 Global Asthma Medication Market Value (US$ Mn) and Volume (Units) (2021-2029)
2.5 Global Asthma Medication Market Value (US$ Mn) and Volume (Units) by Regions
2.5.1 Global Asthma Medication Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
2.5.2 Global Asthma Medication Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
2.6 Global Asthma Medication Market Value (US$ Mn) and Volume (Units) by Product Type
2.6.1 Global Asthma Medication Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
2.6.2 Global Asthma Medication Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
2.7 Global Asthma Medication Market Value (US$ Mn) and Volume (Units) by End User
2.7.1 Global Asthma Medication Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
2.7.2 Global Asthma Medication Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
2.8 Global Asthma Medication Market Y-o-Y Growth Rate Comparison (2014-2029)
2.8.1 Global Asthma Medication Market Y-o-Y Growth Rate by Region
2.8.2 Global Asthma Medication Market Y-o-Y Growth Rate by Product Type
2.8.3 Global Asthma Medication Market Y-o-Y Growth Rate by End User
2.9 Global Asthma Medication Market Share Comparison (2013-2029)
2.9.1 Global Asthma Medication Market Share by Region
2.9.2 Global Asthma Medication Market Share by Product Type
2.9.3 Global Asthma Medication Market Share by End User

Chapter 3 North America Asthma Medication Market Overview

3.1 North America Asthma Medication Market by Product Type
3.1.1 North America Asthma Medication Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
3.1.2 North America Asthma Medication Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
3.1.3 North America Asthma Medication Market Attractiveness Analysis by Product Type, (2013-2020)
3.2 North America Asthma Medication Market by End User
3.2.1 North America Asthma Medication Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
3.2.2 North America Asthma Medication Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
3.2.3 North America Asthma Medication Market Attractiveness Analysis by End User, (2013-2020)
3.3 North America Asthma Medication Market by Region
3.3.1 North America Asthma Medication Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
3.3.2 North America Asthma Medication Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
3.3.3 North America Asthma Medication Market Attractiveness Analysis by Region, (2013-2020)
3.4 North America Asthma Medication Market Outlook (2013-2029)
3.4.1 North America Asthma Medication Market Value (US$ Mn) and Volume (Units) (2013-2020)
3.4.2 North America Asthma Medication Market Value (US$ Mn) and Volume (Units) (2021-2029)
3.5 North America Asthma Medication Market Value (US$ Mn) and Volume (Units) by Regions
3.5.1 North America Asthma Medication Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
3.5.2 North America Asthma Medication Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
3.6 North America Asthma Medication Market Value (US$ Mn) and Volume (Units) by Product Type
3.6.1 North America Asthma Medication Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
3.6.2 North America Asthma Medication Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
3.7 North America Asthma Medication Market Value (US$ Mn) and Volume (Units) by End User
3.7.1 North America Asthma Medication Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
3.7.2 North America Asthma Medication Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
3.8 North America Asthma Medication Market Y-o-Y Growth Rate Comparison (2014-2029)
3.8.1 North America Asthma Medication Market Y-o-Y Growth Rate by Region
3.8.2 North America Asthma Medication Market Y-o-Y Growth Rate by Product Type
3.8.3 North America Asthma Medication Market Y-o-Y Growth Rate by End User
3.9 North America Asthma Medication Market Share Comparison (2013-2029)
3.9.1 North America Asthma Medication Market Share by Region
3.9.2 North America Asthma Medication Market Share by Product Type
3.9.3 North America Asthma Medication Market Share by End User

Chapter 4 Europe Asthma Medication Market Overview

4.1 Europe Asthma Medication Market by Product Type
4.1.1 Europe Asthma Medication Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
4.1.2 Europe Asthma Medication Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
4.1.3 Europe Asthma Medication Market Attractiveness Analysis by Product Type, (2013-2020)
4.2 Europe Asthma Medication Market by End User
4.2.1 Europe Asthma Medication Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
4.2.2 Europe Asthma Medication Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
4.2.3 Europe Asthma Medication Market Attractiveness Analysis by End User, (2013-2020)
4.3 Europe Asthma Medication Market by Region
4.3.1 Europe Asthma Medication Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
4.3.2 Europe Asthma Medication Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
4.3.3 Europe Asthma Medication Market Attractiveness Analysis by Region, (2013-2020)
4.4 Europe Asthma Medication Market Outlook (2013-2029)
4.4.1 Europe Asthma Medication Market Value (US$ Mn) and Volume (Units) (2013-2020)
4.4.2 Europe Asthma Medication Market Value (US$ Mn) and Volume (Units) (2021-2029)
4.5 Europe Asthma Medication Market Value (US$ Mn) and Volume (Units) by Regions
4.5.1 Europe Asthma Medication Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
4.5.2 Europe Asthma Medication Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
4.6 Europe Asthma Medication Market Value (US$ Mn) and Volume (Units) by Product Type
4.6.1 Europe Asthma Medication Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
4.6.2 Europe Asthma Medication Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
4.7 Europe Asthma Medication Market Value (US$ Mn) and Volume (Units) by End User
4.7.1 Europe Asthma Medication Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
4.7.2 Europe Asthma Medication Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
4.8 Europe Asthma Medication Market Y-o-Y Growth Rate Comparison (2014-2029)
4.8.1 Europe Asthma Medication Market Y-o-Y Growth Rate by Region
4.8.2 Europe Asthma Medication Market Y-o-Y Growth Rate by Product Type
4.8.3 Europe Asthma Medication Market Y-o-Y Growth Rate by End User
4.9 Europe Asthma Medication Market Share Comparison (2013-2029)
4.9.1 Europe Asthma Medication Market Share by Region
4.9.2 Europe Asthma Medication Market Share by Product Type
4.9.3 Europe Asthma Medication Market Share by End User

Chapter 5 Asia Pacific Asthma Medication Market Overview

5.1 Asia Pacific Asthma Medication Market by Product Type
5.1.1 Asia Pacific Asthma Medication Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
5.1.2 Asia Pacific Asthma Medication Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
5.1.3 Asia Pacific Asthma Medication Market Attractiveness Analysis by Product Type, (2013-2020)
5.2 Asia Pacific Asthma Medication Market by End User
5.2.1 Asia Pacific Asthma Medication Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
5.2.2 Asia Pacific Asthma Medication Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
5.2.3 Asia Pacific Asthma Medication Market Attractiveness Analysis by End User, (2013-2020)
5.3 Asia Pacific Asthma Medication Market by Region
5.3.1 Asia Pacific Asthma Medication Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
5.3.2 Asia Pacific Asthma Medication Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
5.3.3 Asia Pacific Asthma Medication Market Attractiveness Analysis by Region, (2013-2020)
5.4 Asia Pacific Asthma Medication Market Outlook (2013-2029)
5.4.1 Asia Pacific Asthma Medication Market Value (US$ Mn) and Volume (Units) (2013-2020)
5.4.2 Asia Pacific Asthma Medication Market Value (US$ Mn) and Volume (Units) (2021-2029)
5.5 Asia Pacific Asthma Medication Market Value (US$ Mn) and Volume (Units) by Regions
5.5.1 Asia Pacific Asthma Medication Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
5.5.2 Asia Pacific Asthma Medication Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
5.6 Asia Pacific Asthma Medication Market Value (US$ Mn) and Volume (Units) by Product Type
5.6.1 Asia Pacific Asthma Medication Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
5.6.2 Asia Pacific Asthma Medication Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
5.7 Asia Pacific Asthma Medication Market Value (US$ Mn) and Volume (Units) by End User
5.7.1 Asia Pacific Asthma Medication Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
5.7.2 Asia Pacific Asthma Medication Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
5.8 Asia Pacific Asthma Medication Market Y-o-Y Growth Rate Comparison (2014-2029)
5.8.1 Asia Pacific Asthma Medication Market Y-o-Y Growth Rate by Region
5.8.2 Asia Pacific Asthma Medication Market Y-o-Y Growth Rate by Product Type
5.8.3 Asia Pacific Asthma Medication Market Y-o-Y Growth Rate by End User
5.9 Asia Pacific Asthma Medication Market Share Comparison (2013-2029)
5.9.1 Asia Pacific Asthma Medication Market Share by Region
5.9.2 Asia Pacific Asthma Medication Market Share by Product Type
5.9.3 Asia Pacific Asthma Medication Market Share by End User

Chapter 6 South America Asthma Medication Market Overview

6.1 South America Asthma Medication Market by Product Type
6.1.1 South America Asthma Medication Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
6.1.2 South America Asthma Medication Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
6.1.3 South America Asthma Medication Market Attractiveness Analysis by Product Type, (2013-2020)
6.2 South America Asthma Medication Market by End User
6.2.1 South America Asthma Medication Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
6.2.2 South America Asthma Medication Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
6.2.3 South America Asthma Medication Market Attractiveness Analysis by End User, (2013-2020)
6.3 South America Asthma Medication Market by Region
6.3.1 South America Asthma Medication Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
6.3.2 South America Asthma Medication Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
6.3.3 South America Asthma Medication Market Attractiveness Analysis by Region, (2013-2020)
6.4 South America Asthma Medication Market Outlook (2013-2029)
6.4.1 South America Asthma Medication Market Value (US$ Mn) and Volume (Units) (2013-2020)
6.4.2 South America Asthma Medication Market Value (US$ Mn) and Volume (Units) (2021-2029)
6.5 South America Asthma Medication Market Value (US$ Mn) and Volume (Units) by Regions
6.5.1 South America Asthma Medication Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
6.5.2 South America Asthma Medication Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
6.6 South America Asthma Medication Market Value (US$ Mn) and Volume (Units) by Product Type
6.6.1 South America Asthma Medication Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
6.6.2 South America Asthma Medication Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
6.7 South America Asthma Medication Market Value (US$ Mn) and Volume (Units) by End User
6.7.1 South America Asthma Medication Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
6.7.2 South America Asthma Medication Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
6.8 South America Asthma Medication Market Y-o-Y Growth Rate Comparison (2014-2029)
6.8.1 South America Asthma Medication Market Y-o-Y Growth Rate by Region
6.8.2 South America Asthma Medication Market Y-o-Y Growth Rate by Product Type
6.8.3 South America Asthma Medication Market Y-o-Y Growth Rate by End User
6.9 South America Asthma Medication Market Share Comparison 2013-2029
6.9.1 South America Asthma Medication Market Share by Region
6.9.2 South America Asthma Medication Market Share by Product Type
6.9.3 South America Asthma Medication Market Share by End User

Chapter 7 MEA Asthma Medication Market Overview

7.1 MEA Asthma Medication Market by Product Type
7.1.1 MEA Asthma Medication Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
7.1.2 MEA Asthma Medication Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
7.1.3 MEA Asthma Medication Market Attractiveness Analysis by Product Type, (2013-2020)
7.2 MEA Asthma Medication Market by End User
7.2.1 MEA Asthma Medication Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
7.2.2 MEA Asthma Medication Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
7.2.3 MEA Asthma Medication Market Attractiveness Analysis by End User, (2013-2020)
7.3 MEA Asthma Medication Market by Region
7.3.1 MEA Asthma Medication Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
7.3.2 MEA Asthma Medication Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
7.3.3 MEA Asthma Medication Market Attractiveness Analysis by Region, (2013-2020)
7.4 MEA Asthma Medication Market Outlook (2013-2029)
7.4.1 MEA Asthma Medication Market Value (US$ Mn) and Volume (Units) (2013-2020)
7.4.2 MEA Asthma Medication Market Value (US$ Mn) and Volume (Units) (2021-2029)
7.5 MEA Asthma Medication Market Value (US$ Mn) and Volume (Units) by Regions
7.5.1 MEA Asthma Medication Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
7.5.2 MEA Asthma Medication Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
7.6 MEA Asthma Medication Market Value (US$ Mn) and Volume (Units) by Product Type
7.6.1 MEA Asthma Medication Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
7.6.2 MEA Asthma Medication Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
7.7 MEA Asthma Medication Market Value (US$ Mn) and Volume (Units) by End User
7.7.1 MEA Asthma Medication Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
7.7.2 MEA Asthma Medication Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
7.8 MEA Asthma Medication Market Y-o-Y Growth Rate Comparison (2014-2029)
7.8.1 MEA Asthma Medication Market Y-o-Y Growth Rate by Region
7.8.2 MEA Asthma Medication Market Y-o-Y Growth Rate by Product Type
7.8.3 MEA Asthma Medication Market Y-o-Y Growth Rate by End User
7.9 MEA Asthma Medication Market Share Comparison (2013-2029)
7.9.1 MEA Asthma Medication Market Share by Region
7.9.2 MEA Asthma Medication Market Share by Product Type
7.9.3 MEA Asthma Medication Market Share by End User

Chapter 8 Global Asthma Medication Market Company Profiles

8.1 Market Competition Scenario Analysis, By Company
8.2 Competitor Landscape
8.3 Company Share Analysis
8.4 Company Profiles
8.4.1 Company
8.4.1.1 Company Overview
8.4.1.2 Business Description
8.4.1.3 Product Portfolio
8.4.1.4 Key Financials
8.4.1.5 Key Developments
8.4.1.6 SWOT Analysis

Companies Included:
GlaxoSmithKline (GSK) (United Kingdom)
Novartis AG (Switzerland)
Merck & Co. (United States)
Abbott Laboratories (United States)
Boehringer Ingelheim (Germany)
AstraZeneca (United Kingdom)
Roche Holding AG (Switzerland)
Teva Pharmaceutical Industries (Israel)
Vectura Group (United Kingdom)
Pfizer (United States)
MAP Pharmaceuticals, Inc. (United States)
Genentech Inc. (United States)
Sepracor, Inc. (United States)
Schering-Plough Corp (United States)
Sanofi-Aventis (France)
Theravance Inc. (United States)

Chapter 9 Methodology and Data Source

9.1 Research Approach/ Methodology
9.2 Market Size Estimation
9.3 Market Breakdown and Data Triangulation
9.4 Data Source
9.4.1 Secondary Sources
9.4.2 Primary Sources

Licensing Options

One User
$3900
Enterprise User
$7800